BCYC Insider Trading

Insider Ownership Percentage: 10.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $368,246.68

Bicycle Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Bicycle Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bicycle Therapeutics Share Price & Price History

Current Price: $24.90
Price Change: Price Increase of +0.35 (1.43%)
As of 03/28/2024 01:00 AM ET

This chart shows the closing price history over time for BCYC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Bicycle Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2024Kevin LeeCEOSell8,703$17.50$152,302.50390,428View SEC Filing Icon  
1/3/2024Nigel CrockettInsiderSell2,643$17.50$46,252.5048,716View SEC Filing Icon  
1/3/2024Travis Alvin ThompsonCAOSell604$17.50$10,570.0023,375View SEC Filing Icon  
10/3/2023Alistair MilnesCOOSell442$20.00$8,840.0036,839View SEC Filing Icon  
10/3/2023Kevin LeeCEOSell1,470$20.00$29,400.00322,131View SEC Filing Icon  
10/3/2023Nicholas KeenInsiderSell272$20.00$5,440.0038,233View SEC Filing Icon  
10/3/2023Travis Alvin ThompsonCAOSell54$20.00$1,080.007,979View SEC Filing Icon  
7/3/2023Kevin LeeCEOSell1,498$25.10$37,599.80323,601View SEC Filing Icon  
7/3/2023Michael SkynnerCTOSell451$25.10$11,320.1070,924View SEC Filing Icon  
7/3/2023Nicholas KeenInsiderSell336$25.10$8,433.6038,505View SEC Filing Icon  
7/3/2023Travis Alvin ThompsonCAOSell61$25.10$1,531.108,033View SEC Filing Icon  
4/3/2023Kevin LeeCEOSell1,486$21.11$31,369.46325,099View SEC Filing Icon  
4/3/2023Lee KalowskiCFOSell376$21.11$7,937.3630,309View SEC Filing Icon  
4/3/2023Michael SkynnerCTOSell447$21.11$9,436.1771,375View SEC Filing Icon  
4/3/2023Nicholas KeenInsiderSell319$21.11$6,734.0938,841View SEC Filing Icon  
1/3/2023Kevin LeeCEOSell6,000$29.06$174,360.00326,585View SEC Filing Icon  
1/3/2023Lee KalowskiCFOSell1,815$29.06$52,743.9030,685View SEC Filing Icon  
1/3/2023Nigel CrockettInsiderSell1,801$29.06$52,337.0630,699View SEC Filing Icon  
12/21/2021Pierre LegaultDirectorSell44,537$57.11$2,543,508.07View SEC Filing Icon  
10/18/2021Kevin LeeCEOSell49$60.00$2,940.00View SEC Filing Icon  
10/14/2021Kevin LeeCEOSell4,631$60.00$277,860.00View SEC Filing Icon  
10/11/2021Kevin LeeCEOSell5,000$53.88$269,400.00View SEC Filing Icon  
8/31/2021Kevin LeeCEOSell11,225$36.33$407,804.25View SEC Filing Icon  
8/27/2021Kevin LeeCEOSell1,808$36.02$65,124.16246,893View SEC Filing Icon  
8/27/2021Lee KalowskiCFOSell7,950$35.15$279,442.50550View SEC Filing Icon  
8/23/2021Lee KalowskiCFOSell7,500$33.02$247,650.007,500View SEC Filing Icon  
7/29/2021Lee KalowskiCFOSell12,500$31.51$393,875.0012,500View SEC Filing Icon  
7/26/2021Kevin LeeCEOSell100$36.00$3,600.00View SEC Filing Icon  
7/23/2021Kevin LeeCEOSell4,782$36.02$172,247.64View SEC Filing Icon  
7/16/2021Kevin LeeCEOSell609$34.00$20,706.00View SEC Filing Icon  
7/14/2021Kevin LeeCEOSell14,465$34.34$496,728.10256,670View SEC Filing Icon  
7/13/2021Kate BinghamDirectorSell600$33.50$20,100.00View SEC Filing Icon  
7/13/2021Nigel CrockettInsiderSell72,701$32.44$2,358,420.444,331View SEC Filing Icon  
7/12/2021Kevin LeeCEOSell1,936$32.04$62,029.44View SEC Filing Icon  
7/6/2021Nigel CrockettInsiderSell271$32.00$8,672.00271View SEC Filing Icon  
5/6/2021Kevin LeeCEOSell1,716$32.14$55,152.24256,450View SEC Filing Icon  
5/4/2021Kevin LeeCEOSell897$32.03$28,730.91258,125View SEC Filing Icon  
4/30/2021Kevin LeeCEOSell58,919$30.86$1,818,240.34277,229View SEC Filing Icon  
4/28/2021Kevin LeeCEOSell22,495$31.08$699,144.60277,229View SEC Filing Icon  
4/26/2021Kevin LeeCEOSell18,611$31.28$582,152.08273,345View SEC Filing Icon  
4/8/2021Pierre LegaultDirectorSell24,838$31.71$787,612.9824,838View SEC Filing Icon  
4/5/2021Pierre LegaultDirectorSell162$31.07$5,033.34162View SEC Filing Icon  
3/31/2021Nicholas KeenInsiderSell10,000$30.00$300,000.0028,321View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Bicycle Therapeutics (NASDAQ:BCYC)

86.15% of Bicycle Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCYC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Bicycle Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/22/2024PNC Financial Services Group Inc.7,560$0.14M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD276,837$5.01M0.0%-53.3%0.922%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC6,172$0.11M0.1%+66.6%0.021%Search for SEC Filing on Google Icon
2/15/2024Horizon Kinetics Asset Management LLC14,396$0.26M0.0%-4.0%0.048%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc132,805$2.40M0.0%+43.6%0.442%Search for SEC Filing on Google Icon
2/15/2024Wexford Capital LP34,879$0.63M0.1%N/A0.116%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC15,032$0.27M0.0%+8,847.6%0.050%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD276,837$5.01M0.0%-53.3%0.922%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC312,889$5.66M0.8%+155.0%1.042%Search for SEC Filing on Google Icon
2/15/2024Comerica Bank81,850$1.48M0.0%+18,088.9%0.272%Search for SEC Filing on Google Icon
2/14/2024First Light Asset Management LLC1,550,471$28.03M2.3%-25.1%5.161%Search for SEC Filing on Google Icon
2/14/2024Point72 Asset Management L.P.225,895$4.08M0.0%-82.6%0.752%Search for SEC Filing on Google Icon
2/14/2024Cubist Systematic Strategies LLC113,901$2.06M0.0%+73.8%0.379%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG20,000$0.36M0.0%-49.0%0.067%Search for SEC Filing on Google Icon
2/14/2024Verition Fund Management LLC740,539$13.39M0.1%-19.2%2.465%Search for SEC Filing on Google Icon
2/14/2024Platinum Investment Management Ltd.362,080$6.55M0.3%+26.8%1.205%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 2,328$42K0.0%-76.4%0.008%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC1,536,000$27.77M0.4%+53.6%5.113%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company 13,173$0.24M0.0%-63.5%0.044%Search for SEC Filing on Google Icon
2/12/2024Allianz Asset Management GmbH30,600$0.55M0.0%+80.0%0.102%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc35,186$0.64M0.0%-57.0%0.117%Search for SEC Filing on Google Icon
2/9/2024Westfield Capital Management Co. LP917,304$16.59M0.1%N/A3.054%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP196,323$3.55M0.1%+177.6%0.654%Search for SEC Filing on Google Icon
2/9/2024PNC Financial Services Group Inc.7,560$0.14M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC77,332$1.40M0.0%+108.6%0.257%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets36,851$0.67M0.0%+10,489.4%0.123%Search for SEC Filing on Google Icon
2/5/2024AtonRa Partners10,435$0.19M0.4%-9.9%0.035%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB139,800$2.53M0.0%+3.9%0.465%Search for SEC Filing on Google Icon
1/24/2024Fishman Jay A Ltd. MI34,500$0.62M0.1%-8.0%0.115%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.4,001$72K0.0%+489.2%0.013%Search for SEC Filing on Google Icon
1/8/2024Woodstock Corp21,479$0.39M0.0%+4.5%0.071%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC6,727$0.12M0.0%+34.0%0.022%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG96,370$1.94M0.0%+1,051.4%0.321%Search for SEC Filing on Google Icon
11/22/2023Polar Capital Holdings Plc1,011,500$20.32M0.1%+33.2%3.367%Search for SEC Filing on Google Icon
11/16/2023Morgan Stanley1,621,749$32.58M0.0%+12.7%5.399%Search for SEC Filing on Google Icon
11/15/2023The Manufacturers Life Insurance Company 36,092$0.73M0.0%+43.6%0.120%Search for SEC Filing on Google Icon
11/15/2023RA Capital Management L.P.800,000$16.07M0.3%N/A2.663%Search for SEC Filing on Google Icon
11/15/2023Kennedy Capital Management LLC156,705$3.15M0.1%+27.2%0.522%Search for SEC Filing on Google Icon
11/15/2023Legal & General Group Plc92,463$1.86M0.0%+15.2%0.308%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC1,000,000$20.09M0.3%+14.2%3.329%Search for SEC Filing on Google Icon
11/14/2023Braidwell LP1,289,872$25.91M0.8%N/A4.294%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC52,100$1.05M0.0%-21.2%0.173%Search for SEC Filing on Google Icon
11/14/2023Deerfield Management Company L.P. Series C448,753$9.02M0.2%N/A1.494%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 9,867$0.20M0.0%+307.7%0.033%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP70,719$1.42M0.0%N/A0.235%Search for SEC Filing on Google Icon
11/13/2023Fishman Jay A Ltd. MI37,500$0.75M0.1%+82.9%0.125%Search for SEC Filing on Google Icon
11/13/2023FMR LLC266,347$5.35M0.0%-7.2%0.887%Search for SEC Filing on Google Icon
11/13/2023Maven Securities LTD22,500$0.45M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG96,370$1.94M0.0%+1,051.4%0.321%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG11,305$0.23M0.0%-10.4%0.038%Search for SEC Filing on Google Icon
11/7/2023Alpha DNA Investment Management LLC27,957$0.56M0.2%N/A0.093%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC37,067$0.75M0.0%+104.1%0.123%Search for SEC Filing on Google Icon
11/3/2023Platinum Investment Management Ltd.285,479$5.74M0.2%N/A0.950%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc81,786$1.64M0.0%+246.8%0.272%Search for SEC Filing on Google Icon
10/25/2023BluePath Capital Management LLC1,534$31K0.0%N/A0.005%Search for SEC Filing on Google Icon
10/25/2023AtonRa Partners11,588$0.23M0.5%-18.5%0.039%Search for SEC Filing on Google Icon
10/20/2023Harbor Capital Advisors Inc.24,210$0.49M0.1%+15.0%0.081%Search for SEC Filing on Google Icon
10/17/2023Mach 1 Financial Group LLC24,701$0.50M0.2%N/A0.082%Search for SEC Filing on Google Icon
10/11/2023AE Wealth Management LLC24,773$0.50M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/21/2023Osaic Holdings Inc.2,320$59K0.0%+118.9%0.008%Search for SEC Filing on Google Icon
8/15/2023Fishman Jay A Ltd. MI20,500$0.52M0.1%+95.2%0.068%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.18,215$0.47M0.0%+72.7%0.061%Search for SEC Filing on Google Icon
8/15/2023Point72 Asset Management L.P.478,000$12.20M0.0%-40.4%1.591%Search for SEC Filing on Google Icon
8/15/2023Kennedy Capital Management LLC123,188$3.14M0.1%N/A0.410%Search for SEC Filing on Google Icon
8/15/2023Boothbay Fund Management LLC42,133$1.08M0.0%-49.3%0.140%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 2,420$62K0.0%+91.6%0.008%Search for SEC Filing on Google Icon
8/14/2023Schonfeld Strategic Advisors LLC66,100$1.69M0.0%+10.0%0.220%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP9,271$0.24M0.0%-87.9%0.031%Search for SEC Filing on Google Icon
8/14/2023State Street Corp8,666$0.22M0.0%N/A0.029%Search for SEC Filing on Google Icon
8/14/2023Bellevue Group AG25,000$0.64M0.0%-53.0%0.083%Search for SEC Filing on Google Icon
8/14/2023UniSuper Management Pty Ltd113,458$2.90M0.0%N/A0.378%Search for SEC Filing on Google Icon
8/14/2023Polar Capital Holdings Plc759,500$19.38M0.1%-24.8%2.528%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC9,061$0.23M0.0%-28.3%0.030%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC70,900$1.81M0.0%+14.5%0.236%Search for SEC Filing on Google Icon
8/11/2023Natixis2,775$70K0.0%-18.4%0.009%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.181,108$4.62M0.0%+1.2%0.603%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.96,151$2.45M0.0%+10.3%0.320%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP111,973$2.86M0.0%-8.8%0.373%Search for SEC Filing on Google Icon
8/10/2023Osaic Holdings Inc.2,320$59K0.0%+118.9%0.008%Search for SEC Filing on Google Icon
8/10/2023Tekla Capital Management LLC44,338$1.13M0.0%-50.0%0.148%Search for SEC Filing on Google Icon
8/8/2023Candriam S.C.A.1,273,261$32.49M0.2%-2.3%4.239%Search for SEC Filing on Google Icon
8/2/2023Handelsbanken Fonder AB134,500$3.43M0.0%+2.0%0.448%Search for SEC Filing on Google Icon
7/25/2023DekaBank Deutsche Girozentrale30,000$0.72M0.0%+127.3%0.100%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC5,276$0.14M0.0%N/A0.018%Search for SEC Filing on Google Icon
7/18/2023AtonRa Partners14,219$0.36M0.6%-6.3%0.047%Search for SEC Filing on Google Icon
7/11/2023Harbor Capital Advisors Inc.21,045$0.54M0.1%+10.0%0.070%Search for SEC Filing on Google Icon
7/7/2023Woodstock Corp20,553$0.53M0.1%+10.3%0.068%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC12,634$0.27M0.0%N/A0.059%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.87,138$1.85M0.0%+4.7%0.409%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC9,800$0.21M0.0%N/A0.046%Search for SEC Filing on Google Icon
5/16/2023First Light Asset Management LLC699,328$14.88M1.3%+0.4%3.282%Search for SEC Filing on Google Icon
5/16/2023Armistice Capital LLC736,000$15.66M0.2%N/A3.455%Search for SEC Filing on Google Icon
5/15/2023Schonfeld Strategic Advisors LLC60,100$1.28M0.0%-24.6%0.282%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC43,807$0.93M0.0%+232.1%0.206%Search for SEC Filing on Google Icon
5/15/2023Logos Global Management LP750,000$15.95M2.3%-47.7%3.520%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP187,900$4M0.0%+16.1%0.882%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP160,576$3.42M0.0%N/A0.754%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD318,076$6.77M0.0%-6.1%1.493%Search for SEC Filing on Google Icon
5/15/2023AXA S.A.460,125$9.79M0.0%+20.9%2.160%Search for SEC Filing on Google Icon
5/15/2023Rubric Capital Management LP205,423$4.37M0.1%N/A0.964%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Bicycle Therapeutics logo
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. Its product pipeline comprising BT8009, a bicycle toxin conjugate (BTC) which is in phase I/II and phase II/III clinical trial for the treatment of high nectin-4 expressing tumors; BT5528, a BTC which is in phase I/II clinical trial for the treatment of Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle TICA molecule which is in phase I/II targeting Nectin-4 and agonizing CD137; and BT7455, a Bicycle TICA molecule targeting Ephrin type A receptor 2 and CD137 and is in preclinical trial. The company also developing BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease; and BT7401, a multivalent bicycle CD137 agonist which is in phase IIa to treat advanced solid tumors. In addition, it develops Novel anti-infective, which is in preclinical trial targeting anti-infectives disease; CNS targets, which is in preclinical trial targeting CNS disease; and Novel neuromuscular targets, which is in preclinical trial targeting neuromuscular disease. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas. The company has collaboration and license agreement with Bayer Consumer Care AG; Novartis Pharma AG; Cancer Research UK; Cancer Research Technology Ltd; and Oxurion NV. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.
Read More on Bicycle Therapeutics

Today's Range

Now: $24.90
Low: $24.09
High: $24.97

50 Day Range

MA: $22.00
Low: $16.75
High: $26.10

52 Week Range

Now: $24.90
Low: $12.54
High: $28.91

Volume

205,069 shs

Average Volume

375,700 shs

Market Capitalization

$748.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Bicycle Therapeutics?

Bicycle Therapeutics' top insider investors include:
  1. Kevin Lee (CEO)
  2. Michael Skynner (CTO)
  3. Nigel Crockett (Insider)
  4. Nicholas Keen (Insider)
  5. Alistair Milnes (COO)
  6. Lee Kalowski (CFO)
  7. Travis Alvin Thompson (CAO)
Learn More about top insider investors at Bicycle Therapeutics.

Who are the major institutional investors of Bicycle Therapeutics?

Bicycle Therapeutics' top institutional investors include:
  1. First Light Asset Management LLC — 5.16%
  2. Armistice Capital LLC — 5.11%
  3. Westfield Capital Management Co. LP — 3.05%
  4. Verition Fund Management LLC — 2.47%
  5. Platinum Investment Management Ltd. — 1.21%
  6. Parkman Healthcare Partners LLC — 1.04%
Learn More about top institutional investors of Bicycle Therapeutics stock.

Which major investors are selling Bicycle Therapeutics stock?

During the last quarter, BCYC stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
  2. First Light Asset Management LLC
  3. Price T Rowe Associates Inc. MD
  4. Price T Rowe Associates Inc. MD
  5. Verition Fund Management LLC
  6. Simplex Trading LLC
  7. TD Asset Management Inc
  8. The Manufacturers Life Insurance Company
During the previous year, company insiders that have sold Bicycle Therapeutics company stock include:
  1. Kevin Lee (CEO)
  2. Michael Skynner (CTO)
  3. Nigel Crockett (Insider)
  4. Nicholas Keen (Insider)
  5. Alistair Milnes (COO)
  6. Lee Kalowski (CFO)
  7. Travis Alvin Thompson (CAO)
Learn More investors selling Bicycle Therapeutics stock.

Which major investors are buying Bicycle Therapeutics stock?

During the previous quarter, BCYC stock was acquired by institutional investors including:
  1. Westfield Capital Management Co. LP
  2. Armistice Capital LLC
  3. Parkman Healthcare Partners LLC
  4. Trexquant Investment LP
  5. Comerica Bank
  6. Platinum Investment Management Ltd.
  7. ADAR1 Capital Management LLC
  8. Cubist Systematic Strategies LLC